Evidence map›Paper›PMID 42187589›Full record

Trial reportCurrent oncology (Toronto, Ont.)2026

Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot Study.

Julie Lemieux, Isabelle Côté, Martine Lemay, Sophie Lauzier, Philippe Després, Christine Desbiens, Catherine Doyle, Brigitte Poirier, Amel Baghdadli, Leonardo Di Schiavi Trotta and 1 more

Registry-linked trialAbstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05743686 (Pilot Study of the Use of an App for the Follow-up of Oral Chemotherapy in Breast Cancer Patients), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05743686 nacompletednot on this map

Pilot Study of the Use of an App for the Follow-up of Oral Chemotherapy in Breast Cancer Patients

TypeinterventionalSponsorJulie LemieuxRan2023 to 2025Enrolled28ConditionsBreast Neoplasms, Chemotherapeutic ToxicityArmsApplication
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Julie LemieuxCentre des Maladies du Sein, CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Isabelle CôtéCentre des Maladies du Sein, CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Martine LemayCentre des Maladies du Sein, CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Sophie LauzierCentre de Recherche du CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada.
Philippe DesprésCentre de Recherche du CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada.ORCID 0000-0002-4163-7353
Christine DesbiensCentre des Maladies du Sein, CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Catherine DoyleCentre des Maladies du Sein, CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Brigitte PoirierCentre des Maladies du Sein, CHU de Québec-Université Laval, Quebec City, QC G1S 4L8, Canada.
Amel BaghdadliCentre de Recherche du CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada.
Leonardo Di Schiavi TrottaCentre de Recherche du CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada.
Hermann NabiCentre de Recherche du CHU de Québec-Université Laval, Quebec City, QC G1V 4G2, Canada.ORCID 0000-0002-7832-0413

Funding

Quebec Breast Cancer Foundation 1 million pour Aider - 2020
6 · The paper itself

Abstract

This pilot study (NCT05743686) evaluated the feasibility of a web-based application enabling patients with breast cancer (BC) receiving oral therapy to self-report and manage treatment-related adverse effects (AEs). Patients were enrolled between January and August 2023. Historical controls were used for comparison. Participants used the web-app to self-report AEs daily for 13 weeks, completed the PRO-CTCAE weekly, and completed a questionnaire assessing psychosocial precursor factors associated with treatment adherence. Some patients and healthcare professionals participated in semi-structured interviews. The study included 28 participants and 185 historical controls. Compared with controls, participants had fewer interactions with hospital pharmacists (0 [0-1] vs. 0 [0-7],

Indexed as

Antineoplastic AgentsBreast NeoplasmsDrug-Related Side Effects and Adverse ReactionsMobile ApplicationsMolecular Targeted TherapyAdministration, OralAdultAgedFemaleHumansInternetMiddle AgedPilot ProjectsAntineoplastic Agentsadministrationbreast cancerchemotherapydrug-related side effects and adverse reactionsmobile applicationsoral

Identifiers

PMID42187589
PMCPMC13205787

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.